Peripheral vascular disorders. A pharmacoeconomic and quality-of-life review

PharmacoEconomics

Volumn 11, Issue 3, 1997, Pages 225-236

  Langley, Paul C ^a   Coons, Stephen Joel ^a  

^a UNIVERSITY OF ARIZONA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PENTOXIFYLLINE;

ATHEROSCLEROSIS; CLINICAL TRIAL; HUMAN; PERIPHERAL VASCULAR DISEASE; PHARMACOECONOMICS; PRIORITY JOURNAL; QUALITY OF LIFE; REVIEW;

EID: 0031053608     PISSN: 11707690     EISSN: None     Source Type: Journal    
DOI: 10.2165/00019053-199711030-00004     Document Type: Review

References (29)

1. Scott HM, Scott WG. Critical leg ischaemia in New Zealand. Pharmacoeconomics 1994; 6 (2): 149-54
2. Frohlich JJ. Cost effective diagnosis and treatment of atherosclerosis. Can J Cardiol 1995; 11 Suppl. C: 41C-2C
3. Superko HR. Sophisticated primary and secondary atherosclerosis prevention is cost effective. Can J Cardiol 1995; 11 Suppl. C: 35C-40C
4. Gould KL. Reversal of coronary atherosclerosis. Circulation 1994; 90 (3): 1559-71
5. Stergachis A, Sheingold S, Luce BR, et al. Medical care and cost outcomes after pentoxifylline treatment for peripheral arterial disease. Arch Intern Med 1992; 152: 1220-4
6. Neels K, Finkelstein S, Douglass C. Medical cost savings from pentoxifylline therapy in chronic occlusive arterial disease. Pharmacoeconomics 1994; 5 (2): 130-40
7. Jeans WD, Danton RM, Baird RN, et al. A comparison of the costs of vascular surgery and balloon dilation in lower limb ischaemic disease. Br J Radiol 1986; 59: 453-6
8. Doubilet P, Abrams HL. The cost of underutilisation of percutaneous transluminal angioplasty for peripheral vascular disease. N Engl J Med 1984; 310 (2): 95-102
9. Gupta SK, Veith FJ, Ascer E, et al. Cost factors in limb-threatening ischaemia due to infrainguinal arteriosclerosis. Eur J Vasc Surg 1988; 2: 151-4
10. Veith FJ, Gupta SK, Samson RH, et al. Progress in limb salvage by reconstructive arterial surgery combined with new or improved adjunctive procedures. Ann Surg 1981; 194: 386-401
11. Mackey WC, McCullough JL, Conlon TP, et al. The costs of surgery for limb threatening ischaemia. Surgery 1986; 99: 26-35
12. Gregg RO. Bypass or amputation? Concomitant reviews of bypass arterial grafting and major amputations. Am J Surg 1985; 149: 397-402
13. Barnes RW. The non-invasive vascular laboratory: who needs it? Cardiovasc Surg 1995; 3 (3): 261-4
14. Fillinger MF, Zwolak RM, Musson AM, et al. Vascular laboratory cost analysis and the impact of the resource-based relative value scale payment system. J Vasc Surg 1993; 17: 267-279
15. Fillinger MR, Zwolak RM. Will the vascular laboratory remain economically viable? Impact of the RBRS payment system. Semin Vasc Surg 1994; 7 (4): 251-60
16. Yin D, Baum RA, Carpenter JP, et al. Cost-effectiveness of magnetic resonance angiography in cases of limb-threatening peripheral vascular disease. Radiology 1995; 194 (3): 757-64
17. Coons SJ, Kaplan RM. Assessing health-related quality of life: application to drug therapy. Clin Ther 1992; 14: 850-8
18. Kongpatanakul S, Strom BL. Quality of life, health status and clinical drug research. Pharmacoeconomics 1992; 2: 8-14
19. Smith M. Medication, quality of life and compliance: the role of the pharmacist. Pharmacoeconomics 1992: 1; 225-30
20. Gillings DB. Pentoxyfylline and intermittent claudication: review of clinical trials and cost-effectiveness analyses. J Cardiovasc Pharmacol 1995; 25 (2 Suppl.): 44-50
21. Robinson L. Chronic arterial occlusive disease of the lower extremity. J Vasc Nurs 1991; 9 (2): 2-7
22. Crosby FE, Ventura MR, Frainier MA, et al. Well-being and concerns of patients with peripheral arterial occlusive disease. J Vasc Nurs 1993 Mar; 11 (1): 5-11
23. Hunt SM, McEwen J, McKenna SP, et al. Subjective health of patients with peripheral vascular disease. Practitioner 1982 Jan; 226: 133-6
24. Arfvidsson B, Karlsson J, Dahloff A-G, et al. The impact of intermittent claudication on quality of life evaluated by the Sickness Impact Profile. Eur J Clin Invest 1993; 23; 741-5
25. Albers M, Fratezi AC, De Luccia N. Assessment of quality of life of patients with severe ischemia as a result of infrainguinal arterial occlusive disease. J Vasc Surg 1992 Jul; 16 (1): 54-9
26. Spitzer WO, Dobson AJ, Hall AJ, et al. Measuring the quality of life of cancer patients: a concise QL-index for use by physicians. J Chron Dis 1981; 34: 585-97
27. Gibbons GW, Burgess AM, Guadagnoli E, et al. Return to well-being and function after infrainguinal revascularization. J Vasc Surg 1995 Jan; 21 (1): 35-45
28. Tunis SR, Bass EB, Steinberg EP. The use of angioplasty, bypass surgery and amputation in the management of peripheral vascular disease. N Engl J Med 1991; 325: 556-62
29. Pell JP, Donnan PT, Fowkes FGR, et al. Quality of life following lower limb amputation for peripheral arterial disease. Eur J Vasc Surg 1993 Jul; 7: 448-51